Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 3

eBook: US $39 Special Offer (PDF + Printed Copy): US $176
Printed Copy: US $157
Library License: US $156
ISSN: 2451-8905 (Print)
ISSN: 2215-0803 (Online)
ISBN: 978-1-68108-290-5 (Print)
ISBN: 978-1-68108-289-9 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810828991160301

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents is an eBook series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.

The third volume of the eBook series begins with a detailed review of the molecular biology of inhibitors that target EGF-family receptors. This review is divided into two parts that covers extracellular and intracellular molecules. Other reviews cover targeted therapies for cancers such as melanoma, follicular lymphoma and topics such as cancer immunotherapy, apoptosis targeting and the Warburg Effect.

ADD A COMMENT

Your Rating *

RELATED BOOKS

.Modern Cancer Therapies and Traditional Medicine: An Integrative Approach to Combat Cancers.
.Frontiers in Anti-Cancer Drug Discovery.
.Current and Future Application of Artificial Intelligence in Clinical Medicine.
.Thrombosis in Cancer: .